Y
Yang Feng
Researcher at GlaxoSmithKline
Publications - 7
Citations - 374
Yang Feng is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 6, co-authored 6 publications receiving 335 citations.
Papers
More filters
Journal ArticleDOI
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3–17 years
Joseph B. Domachowske,Heidemarie Pankow-Culot,Milagros Bautista,Yang Feng,Carine Claeys,Mathieu Peeters,Bruce L. Innis,Varsha K. Jain +7 more
TL;DR: QIV vs TIV showed superior immunogenicity for the additional B strain without interfering with immune responses to shared strains, suggesting QIV may offer improved protection against influenza B in children compared with current trivalent vaccines.
Journal ArticleDOI
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
Dorothee Kieninger,Eric Sheldon,Wen-Yuan Lin,Chong-Jen Yu,José M. Bayas,Julian J. Gabor,Meral Esen,Jose Luis Fernandez Roure,Silvia Narejos Perez,C. Sanchez,Yang Feng,Carine Claeys,Mathieu Peeters,Bruce L. Innis,Varsha K. Jain +14 more
TL;DR: QIV provided superior immunogenicity for the additional B strain compared with TIV, without interfering with antibody responses to the three shared antigens, suggesting that the candidate QIV is a viable alternative to TIV for use in adults, and could potentially improve protection against influenza B.
Journal ArticleDOI
Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample.
Sylvia Taylor,Pio Lopez,Lily Yin Weckx,Charissa Borja-Tabora,Rolando Ulloa-Gutierrez,Eduardo Lazcano-Ponce,Angkool Kerdpanich,Miguel Angel Rodriguez Weber,Abiel Mascareñas de los Santos,Juan Carlos Tinoco,Marco Aurélio Palazzi Sáfadi,Fong Seng Lim,Marcela Hernandez-de Mezerville,Idis Faingezicht,Aurelio Cruz-Valdez,Yang Feng,Ping Li,Serge Durviaux,Gerco Haars,Sumita Roy-Ghanta,David W. Vaughn,Terry Nolan +21 more
TL;DR: Active surveillance of healthy children provided evidence of respiratory illness burden associated with several viruses, with a substantial burden in older children.
Journal ArticleDOI
Prevalence and Incidence of Respiratory Syncytial Virus and Other Respiratory Viral Infections in Children Aged 6 Months to 10 Years With Influenza-like Illness Enrolled in a Randomized Trial
Terry Nolan,Charissa Borja-Tabora,Pio Lopez,Lily Yin Weckx,Rolando Ulloa-Gutierrez,Eduardo Lazcano-Ponce,Angkool Kerdpanich,Miguel Angel Rodriguez Weber,Abiel Mascareñas de los Santos,Juan Carlos Tinoco,Marco Aurélio Palazzi Sáfadi,Lim Fong Seng,Marcela Hernandez-de Mezerville,Idis Faingezicht,Aurelio Cruz-Valdez,Yang Feng,Ping Li,Serge Durviaux,Gerco Haars,Sumita Roy-Ghanta,David W. Vaughn,Sylvia Taylor +21 more
TL;DR: In children aged 6 months to <10 years, the incidence of influenza-like illness associated with respiratory syncytial virus was 7.0 per 100 person-years, which may inform vaccination strategies.
Journal ArticleDOI
Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age.
Miguel Angel Rodriguez Weber,Carine Claeys,Carlos Aranza Doniz,Yang Feng,Bruce L. Innis,Varsha K. Jain,Mathieu Peeters +6 more
TL;DR: QIV provided superior immunogenicity for the alternate-lineage B strain compared with TIV without interfering with immune responses to shared strains and Reactogenicity and safety of QIV was consistent with Tiv.